Study Details

Back
Study ID F506-CL-0602
Study Title FK506 Phase 3 Open Study in Myasthenia Gravis (MG) - An Open Study in Steroid Resistant, Non-Thymectomized MG Patients -
Clinicaltrials.gov Identifier NCT00309101
Compound Name FK506 / tacrolimus
Medical Indication or Disease Myasthenia gravis
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 26-Apr-2006
Study Completion Date 26-Feb-2009
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS